乳腺癌中巨噬细胞调控与天然成分干预研究
摘要
皮-间质转化及基质重塑等促转移机制。针对常规靶向治疗的局限,重点综述天然成分与中蒙药多靶点调控TAMs
表型的进展。其低毒性与整体调节优势,为乳腺癌抗转移新疗法提供了理论及转化思路。
关键词
全文:
PDF参考
[1]Yang H, Yang J, Zheng X, et al. The hippo pathway
in breast cancer: The extracellular matrix and hypoxia [J]. Int J
Mol Sci, 2024, 25(23).
[2]Pavlova A, Mushii O, Bazas V, et al. Tumor-associated
macrophages: Relationship with clinical status of patients and
molecular biological features of breast cancer [J]. Exp Oncol,
2025, 47(2): 197-206.
[3]Tan Y, Luo X, Lv W, et al. Tumor-derived exosomal
components: The multifaceted roles and mechanisms in breast
cancer metastasis [J]. Cell Death Dis, 2021, 12(6): 547.
[4]Hao C, Sheng Z, Wang W, et al. Tumor-derived
exosomal mir-148b-3p mediates m2 macrophage polarization
via tsc2/mtorc1 to promote breast cancer migration and
invasion [J]. Thorac Cancer, 2023, 14(16): 1477-91.
[5]Autio KA, Klebanoff CA, Schaer D, et al.
Immunomodulatory activity of a colony-stimulating factor-1
receptor inhibitor in patients with advanced refractory breast
or prostate cancer: A phase i study [J]. Clin Cancer Res, 2020,
26(21): 5609-20.
[6]Mehta AK, Cheney EM, Hartl CA, et al. Targeting
immunosuppressive macrophages overcomes parp inhibitor
resistance in brca1-associated triple-negative breast cancer [J].
Nat Cancer, 2021, 2(1): 66-82.
[7]Liu K, Li J, Sun Z, et al. Chelidonine-induced
inhibition of fbp1 disrupts m2 macrophage polarization and
attenuates breast cancer [J]. Phytomedicine, 2025, 148: 157451.
[8]Cheng Y, Zhong X, Nie X, et al. Glycyrrhetinic
acid suppresses breast cancer metastasis by inhibiting m2-like
macrophage polarization via activating jnk1/2 signaling [J].
Phytomedicine, 2023, 114: 154757.
[9]Ji G, Wang P, Kong Z, et al. Remodeling the tumor
microenvironment: Regulatory effects of β-sitosterol and
luteolin on the immunosuppressive milieu in endometrial
carcinoma and implications for combinatorial immunotherapy
[J]. Front Immunol, 2025, 16: 1669606.
[10]Dai T, Xu Z, Li Y, et al. Promotion of the invasion
and metastasis of breast cancer by b7-h3 through ccr5high
tumor-associated macrophages [J]. Cancer Cell Int, 2025,
25(1): 293.
[11]Xiao M, Bian Q, Lao Y, et al. Senp3 loss promotes
m2 macrophage polarization and breast cancer progression [J].
Mol Oncol, 2022, 16(4): 1026-44.
[12]Bhatia JK, Malik A, Chaudhary T, et al. Evaluation
of number density of tumor-associated macrophages by
immunohistochemistry and semiquantitative scoring in invasive
breast cancer: An indian study [J]. J Microsc Ultrastruct, 2023,
11(4): 214-9.
[13]Tao S, Zhao Z, Zhang X, et al. The role of
macrophages during breast cancer development and response to
chemotherapy [J]. Clin Transl Oncol, 2020, 22(11): 1938-51.
[14]Mohamed HT, El-Sharkawy AA, El-Shinawi M,
et al. Inflammatory breast cancer: The secretome of hcmv(+)
tumor-associated macrophages enhances proliferation,
invasion, colony formation, and expression of cancer stem cell
markers [J]. Front Oncol, 2022, 12: 899622.[15]Chen C, Guo S, Chai W, et al. A comprehensive
genome-based analysis identifies the anti-cancerous role of
the anoikis-related gene adh1a in modulating the pathogenesis
of breast cancer [J]. Mol Genet Genomics, 2024, 299(1): 108.
[16]Ou Y, Jiang HM, Wang YJ, et al. The zeb1-cxcl1
axis impairs the antitumor immune response by inducing m2
macrophage polarization in breast cancer [J]. Am J Cancer
Res, 2024, 14(9): 4378-97.
[17]Deswal B, Bagchi U, Santra MK, et al. Inhibition
of stat3 by 2-methoxyestradiol suppresses m2 polarization
and protumoral functions of macrophages in breast cancer [J].
BMC Cancer, 2024, 24(1): 1129.
[18]Nguyen HT, Kan EL, Humayun M, et al. Patientspecific vascularized tumor model: Blocking monocyte
recruitment with multispecific antibodies targeting ccr2 and
csf-1r [J]. Biomaterials, 2025, 312: 122731.
[19]Klemm F, Möckl A, Salamero-Boix A, et al.
Compensatory csf2-driven macrophage activation promotes
adaptive resistance to csf1r inhibition in breast-to-brain
metastasis [J]. Nat Cancer, 2021, 2(10): 1086-101.
[20]Ramli RR, Muhammad SNH, Azlan M, et al.
Lutein reverses m2 macrophages polarization and exhibits
antitumor effects on human triple-negative breast cancer cells
[J]. Mol Biol Rep, 2026, 53(1): 295.
Refbacks
- 当前没有refback。
